Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $2.17 billion. The enterprise value is $1.79 billion.
| Market Cap | 2.17B |
| Enterprise Value | 1.79B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 133.05 million shares outstanding. The number of shares has decreased by -5.66% in one year.
| Current Share Class | 133.05M |
| Shares Outstanding | 133.05M |
| Shares Change (YoY) | -5.66% |
| Shares Change (QoQ) | -2.99% |
| Owned by Insiders (%) | 2.28% |
| Owned by Institutions (%) | 63.23% |
| Float | 129.10M |
Valuation Ratios
The trailing PE ratio is 7.07 and the forward PE ratio is 20.88.
| PE Ratio | 7.07 |
| Forward PE | 20.88 |
| PS Ratio | 6.96 |
| Forward PS | 6.36 |
| PB Ratio | 3.52 |
| P/TBV Ratio | 3.54 |
| P/FCF Ratio | 12.38 |
| P/OCF Ratio | 12.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.95, with an EV/FCF ratio of 10.22.
| EV / Earnings | 5.69 |
| EV / Sales | 5.74 |
| EV / EBITDA | 9.95 |
| EV / EBIT | 11.15 |
| EV / FCF | 10.22 |
Financial Position
The company has a current ratio of 5.42, with a Debt / Equity ratio of 0.10.
| Current Ratio | 5.42 |
| Quick Ratio | 4.86 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.36 |
| Debt / FCF | 0.37 |
| Interest Coverage | 39.08 |
Financial Efficiency
Return on equity (ROE) is 66.12% and return on invested capital (ROIC) is 65.00%.
| Return on Equity (ROE) | 66.12% |
| Return on Assets (ROA) | 15.49% |
| Return on Invested Capital (ROIC) | 65.00% |
| Return on Capital Employed (ROCE) | 23.17% |
| Weighted Average Cost of Capital (WACC) | 11.76% |
| Revenue Per Employee | $2.43M |
| Profits Per Employee | $2.45M |
| Employee Count | 128 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.50 |
Taxes
| Income Tax | -153.75M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.52% in the last 52 weeks. The beta is 1.40, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +34.52% |
| 50-Day Moving Average | 15.99 |
| 200-Day Moving Average | 15.47 |
| Relative Strength Index (RSI) | 53.97 |
| Average Volume (20 Days) | 1,160,503 |
Short Selling Information
The latest short interest is 9.62 million, so 7.23% of the outstanding shares have been sold short.
| Short Interest | 9.62M |
| Short Previous Month | 9.53M |
| Short % of Shares Out | 7.23% |
| Short % of Float | 7.45% |
| Short Ratio (days to cover) | 8.77 |
Income Statement
In the last 12 months, AUPH had revenue of $311.51 million and earned $314.11 million in profits. Earnings per share was $2.30.
| Revenue | 311.51M |
| Gross Profit | 242.61M |
| Operating Income | 160.45M |
| Pretax Income | 160.36M |
| Net Income | 314.11M |
| EBITDA | 179.83M |
| EBIT | 160.45M |
| Earnings Per Share (EPS) | $2.30 |
Balance Sheet
The company has $443.02 million in cash and $64.14 million in debt, with a net cash position of $378.89 million or $2.85 per share.
| Cash & Cash Equivalents | 443.02M |
| Total Debt | 64.14M |
| Net Cash | 378.89M |
| Net Cash Per Share | $2.85 |
| Equity (Book Value) | 614.86M |
| Book Value Per Share | 4.63 |
| Working Capital | 441.43M |
Cash Flow
In the last 12 months, operating cash flow was $175.24 million and capital expenditures -$176,000, giving a free cash flow of $175.07 million.
| Operating Cash Flow | 175.24M |
| Capital Expenditures | -176,000 |
| Depreciation & Amortization | 19.38M |
| Net Borrowing | -13.99M |
| Free Cash Flow | 175.07M |
| FCF Per Share | $1.32 |
Margins
Gross margin is 77.88%, with operating and profit margins of 51.51% and 100.84%.
| Gross Margin | 77.88% |
| Operating Margin | 51.51% |
| Pretax Margin | 51.48% |
| Profit Margin | 100.84% |
| EBITDA Margin | 57.73% |
| EBIT Margin | 51.51% |
| FCF Margin | 56.20% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.66% |
| Shareholder Yield | 5.66% |
| Earnings Yield | 14.49% |
| FCF Yield | 8.08% |
Analyst Forecast
The average price target for AUPH is $17.86, which is 9.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.86 |
| Price Target Difference | 9.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 15.81% |
| EPS Growth Forecast (3Y) | -17.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AUPH has an Altman Z-Score of 6.89 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.89 |
| Piotroski F-Score | 4 |